SCHEMBL6848813

SCHEMBL6848813

NCC(=O)NS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.64
CA2 P00918 3/20 0.64
MMP1 P03956 3/20 0.57
MMP12 P39900 2/20 0.57
GAA P10253 1/20 0.57
MMP2 P08253 11/20 0.56
MMP9 P14780 9/20 0.56
MMP3 P08254 2/20 0.56
MMP7 P09237 2/20 0.56
MMP13 P45452 2/20 0.56
MMP14 P50281 2/20 0.56
MMP8 P22894 1/20 0.56
ADAM17 P78536 1/20 0.56
MEP1B Q16820 1/20 0.56
BCL2L1 Q07817 2/20 0.52
MCL1 Q07820 2/20 0.52
ADAMTS4 O75173 2/20 0.50
CA12 O43570 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3928657 0.90 CA1 (0.67) CA1CA2MMP1MMP2MMP9
SCHEMBL4464537 0.81 CA1 (0.70) CA1CA2MMP1MMP2MMP9
SCHEMBL13537908 0.79 CA1 (0.68) CA1CA2MMP1MMP2MMP9
SCHEMBL6850444 0.79 EGFR (0.68) CA1CA2MMP1MMP2MMP9
SCHEMBL3928646 0.79 EGFR (0.68) CA1CA2MMP1MMP2MMP9
SCHEMBL5071025 0.79 PTGS2 (0.82) CA1CA2CA12CA9CA14
SCHEMBL15633548 0.78 MMP2 (0.52) CA1CA2MMP1MMP12GAA
SCHEMBL6848742 0.78 RAPGEF3 (0.59) CA1CA2SLC1A3SLC1A2SLC1A1
SCHEMBL15625449 0.77 PTGS2 (0.63) CA1CA2MMP1MMP12GAA
SCHEMBL1161379 0.77 EGFR (0.55) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774212-B2 FOR THERAPY OF VIRAL INFECTION OR AS AN ASSAY STANDARD OR REAGENT BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-10 US disclosed